ICU Medical Announces Time of Third Quarter 2025 Earnings Conference Call
ICU Medical (Nasdaq: ICUI) will release its third quarter 2025 results on Thursday, November 6, 2025 at approximately 4:00 p.m. ET (1:00 p.m. PT). The company will host a conference call to discuss results on November 6, 2025 at 4:30 p.m. ET (1:30 p.m. PT).
Investors can join by phone at (800) 267-6316 with conference ID “ICUMED”, or listen via webcast on the company website under the Investors > Webcast section. A replay of the webcast will be available after the call.
ICU Medical (Nasdaq: ICUI) presenterà i risultati del terzo trimestre 2025 il giovedì 6 novembre 2025 alle 16:00 ET (1:00 PT). L'azienda terrà una conferenza telefonica per discutere i risultati il 6 novembre 2025 alle 16:30 ET (13:30 PT).
Gli investitori possono partecipare telefonicamente al numero (800) 267-6316 con l'ID della conferenza "ICUMED", oppure ascoltare tramite webcast sul sito web aziendale nella sezione Investitori > Webcast. Una riproduzione del webcast sarà disponibile dopo la chiamata.
ICU Medical (Nasdaq: ICUI) publicará sus resultados del tercer trimestre 2025 el jueves 6 de noviembre de 2025 aproximadamente a las 4:00 p.m. ET (1:00 p.m. PT). La empresa organizará una conferencia telefónica para discutir los resultados el 6 de noviembre de 2025 a las 4:30 p.m. ET (1:30 p.m. PT).
Los inversionistas pueden unirse por teléfono al (800) 267-6316 con el identificador de conferencia "ICUMED", o escuchar vía webcast en el sitio web de la empresa en la sección Inversores > Webcast. Habrá una grabación del webcast disponible después de la llamada.
ICU Medical (Nasdaq: ICUI)은 2025년 3분기 실적을 2025년 11월 6일 목요일에 동부표준시 4:00 p.m. (태평양표준시 1:00 p.m.)에 발표합니다. 회사는 2025년 11월 6일 4:30 p.m. ET (1:30 p.m. PT)에 실적 발표 관련 컨퍼런스 콜을 개최합니다.
투자자들은 전화로 (800) 267-6316 번호와 컨퍼런스 ID "ICUMED"로 참가하거나, 회사 웹사이트의 Investors > Webcast 섹션에서 웹캐스트를 통해 청취할 수 있습니다. 콜 이후에 웹캐스트의 재생이 제공됩니다.
ICU Medical (Nasdaq: ICUI) publiera ses résultats du troisième trimestre 2025 le jeudi 6 novembre 2025 vers environ 16 h 00 ET (1 h PT). L'entreprise organisera une conférence téléphonique pour discuter des résultats le 6 novembre 2025 à 16 h 30 ET (13 h 30 PT).
Les investisseurs peuvent joindre par téléphone au (800) 267-6316 avec l'identifiant de conférence "ICUMED", ou écouter via webcast sur le site de l'entreprise dans la section Investisseurs > Webcast. Une rediffusion du webcast sera disponible après l'appel.
ICU Medical (Nasdaq: ICUI) wird seine Ergebnisse des dritten Quartals 2025 am Donnerstag, den 6. November 2025 ca. 16:00 Uhr ET (1:00 Uhr PT) bekannt geben. Das Unternehmen wird eine Telefonkonferenz abhalten, um die Ergebnisse am 6. November 2025 um 16:30 Uhr ET (1:30 Uhr PT) zu besprechen.
Investoren können sich telefonisch unter der Nummer (800) 267-6316 mit der Konferenz-ID "ICUMED" verbinden oder über den Webcast auf der Unternehmenswebsite unter dem Bereich Investoren > Webcast anhören. Eine Wiederholung des Webcasts wird nach dem Anruf verfügbar sein.
ICU Medical (ناسداك: ICUI) سيكشف عن نتائجه للربع الثالث من عام 2025 في يوم الخميس 6 نوفمبر 2025 تقريباً في الساعة 4:00 مساءً بتوقيت شرق الولايات المتحدة (1:00 مساءً بتوقيت المحيط الهادئ). ستعقد الشركة مكالمة مؤتمر لمناقشة النتائج في 6 نوفمبر 2025 الساعة 4:30 مساءً ET (1:30 مساءً بتوقيت PT).
يمكن للمستثمرين الانضمام عبر الهاتف على الرقم (800) 267-6316 مع مُعرّف المؤتمر "ICUMED"، أو الاستماع عبر بث ويب على موقع الشركة ضمن قسم المستثمرين > بث ويب. سيكون هناك إعادة تشغيل للبث بعد المكالمة.
ICU Medical (纳斯达克:ICUI) 将在 2025 年 3 季度 的结果于 2025 年 11 月 6 日(星期四) 左右公布,时间约在 美东时间 16:00(太平洋时间 13:00)。公司将于 2025 年 11 月 6 日 16:30 ET(13:30 PT)举行电话会议讨论结果。
投资者可通过电话拨打 (800) 267-6316,会议ID “ICUMED”,也可在公司网站的 投资者 > 网络广播 部分通过网络收听。电话会议结束后,网络广播将有回放。
- None.
- None.
SAN CLEMENTE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2025 earnings release and conference call.
The Company will release its third quarter 2025 results on Thursday, November 6, 2025 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, November 6, 2025. The call can be accessed at (800) 267-6316, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical
ICU Medical (Nasdaq:ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.
CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.